Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism

Jordan M Thompson1, Alejandro Alvarez1, Monika K Singha1

  • 1Molecular Biology and Biochemistry Department, University of California Irvine, Irvine, California.

Insights

Statins, HMG-CoA reductase inhibitors, show promise as a new treatment for clear cell renal cell carcinoma (CC-RCC). They are synthetically lethal with von Hippel-Lindau (VHL) gene loss, a common CC-RCC driver.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Clear cell renal cell carcinoma (CC-RCC) presents limited treatment options for advanced stages.
  • The von Hippel-Lindau (VHL) tumor suppressor gene is lost in 90% of CC-RCC cases, driving disease progression.

Purpose of the Study:

  • To investigate HMG-CoA reductase inhibitors (statins) as potential therapeutics for CC-RCC.
  • To explore the synthetic lethality between statins and VHL gene loss in CC-RCC.

Main Methods:

  • Utilized three different CC-RCC cell lines and three lipophilic statins.
  • Assessed the impact of statin treatment on VHL-deficient CC-RCC cell viability and tumor growth in mice.
  • Investigated the rescue mechanisms of the synthetic lethal effect using mevalonate, geranylgeranylpyrophosphate, and squalene.

Main Results:

  • Statin treatment demonstrated synthetic lethality with VHL loss in CC-RCC.
  • Statins induced cytostatic and cytotoxic effects in VHL-deficient CC-RCC cells at nanomolar and micromolar concentrations, respectively.
  • The synthetic lethality was attributed to the disruption of small GTPase isoprenylation, involving Rho/ROCK and HIF signaling pathways.
  • Statin treatment inhibited tumor initiation and progression in a mouse model of CC-RCC.

Conclusions:

  • Statins represent a potential therapeutic strategy for VHL-deficient CC-RCC.
  • Targeting mevalonate synthesis and subsequent isoprenylation is a promising approach for CC-RCC treatment.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Frequency-dependent Selection01:21

Frequency-dependent Selection

When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.2K